For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Arm A (Rose Geranium in Sesame Oil Nasal Spray) | Rose Geranium in Sesame Oil Nasal Spray: Instill intranasally | 0 | None | 0 | 53 | 10 | 53 | View |
| Arm B (Isotonic Nasal Saline) | Rose Geranium in Sesame Oil Nasal Spray: Instill intranasally | 0 | None | 0 | 53 | 9 | 53 | View |
| Arm A Crossover | Rose Geranium in Sesame Oil Nasal Spray: Instill intranasally | 0 | None | 0 | 2 | 0 | 2 | View |
| Arm B Crossover | Rose Geranium in Sesame Oil Nasal Spray: Instill intranasally | 0 | None | 0 | 37 | 4 | 37 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE 5 | View |
| Blood and lymph sys disorders - Oth Spec | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCAE 5 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 5 | View |
| Oral pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCAE 5 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 5 | View |
| Flu like symptoms | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 5 | View |
| Gen disord and admin site conds-Oth spec | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 5 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCAE 5 | View |
| Infections and infestations - Oth spec | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCAE 5 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 5 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 5 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCAE 5 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCAE 5 | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCAE 5 | View |
| Superficial soft tissue fibrosis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCAE 5 | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 5 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 5 | View |
| Paresthesia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 5 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCAE 5 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 5 | View |
| Nasal congestion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 5 | View |
| Oropharyngeal pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 5 | View |
| Postnasal drip | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCAE 5 | View |
| Skin and subcut tissue disord - Oth spec | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCAE 5 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCAE 5 | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCAE 5 | View |